down arrow

Mangalam Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE584F01014
  • NSEID: MANGALAM
  • BSEID: 532637
INR
75.50
0.85 (1.14%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 8.82 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

75.4180.00

52 Week

70.11144.65
Valuation
Technical
Day's Volume

CASH

8.82 k (-55.07%) Volume

Shareholding (Dec 2024)

FII

0.11%

Held by 1 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

50.30%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Weak Long Term Fundamental Strength with a 19.24% CAGR growth in Operating Profits over the last 5 years

 
2

Stock is technically in a Bearish range

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 120 Cr (Micro Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.52

stock-summary
Return on Equity

7.00%

stock-summary
Price to Book

0.80

Revenue and Profits (1 Year):
Net Sales:
89 Cr
(Quarterly Results - Dec 2024)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-39.19%
0%
-39.19%
1 Year
-25.75%
0%
-25.75%
2 Years
-34.14%
0%
-34.14%
3 Years
-43.32%
0%
-43.32%
4 Years
-35.5%
0%
-35.5%
5 Years
95.6%
0%
95.6%

Latest dividend: 0.5 per share ex-dividend date: Dec-21-2017

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.47%
EBIT Growth (5y)
19.24%
EBIT to Interest (avg)
2.17
Debt to EBITDA (avg)
3.70
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.77
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
11.01%
Institutional Holding
0.11%
ROCE (avg)
11.47%
ROE (avg)
10.09%
Valuation key factors
Factor
Value
P/E Ratio
11
Industry P/E
33
Price to Book Value
0.80
EV to EBIT
8.99
EV to EBITDA
5.23
EV to Capital Employed
0.87
EV to Sales
0.56
PEG Ratio
0.07
Dividend Yield
NA
ROCE (Latest)
9.01%
ROE (Latest)
7.00%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

11.0148

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.11%)

Promoter with highest holding

Shri Jb Pharma Private Limited (16.74%)

Highest Public shareholder

Ashutosh Taparia (1.91%)

Individual Investors Holdings

44.78%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 11.03% vs 4.26% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -47.96% vs 0.37% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "88.55",
          "val2": "79.75",
          "chgp": "11.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.77",
          "val2": "8.69",
          "chgp": "0.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.49",
          "val2": "3.67",
          "chgp": "-4.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.40",
          "val2": "2.69",
          "chgp": "-47.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "9.90%",
          "val2": "10.90%",
          "chgp": "-1.00%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -7.20% vs -21.35% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 140.99% vs -350.48% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "156.25",
          "val2": "168.37",
          "chgp": "-7.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.88",
          "val2": "-1.28",
          "chgp": "1,418.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.41",
          "val2": "6.66",
          "chgp": "11.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.37",
          "val2": "-13.10",
          "chgp": "140.99%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.80%",
          "val2": "-0.76%",
          "chgp": "11.56%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -7.77% vs -4.18% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 153.73% vs -322.61% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "244.80",
          "val2": "265.42",
          "chgp": "-7.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25.65",
          "val2": "5.70",
          "chgp": "350.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "10.90",
          "val2": "9.97",
          "chgp": "9.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "6.77",
          "val2": "-12.60",
          "chgp": "153.73%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.46%",
          "val2": "2.14%",
          "chgp": "8.32%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -0.77% vs -17.89% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -812.60% vs -93.54% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "367.35",
          "val2": "370.20",
          "chgp": "-0.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17.39",
          "val2": "25.73",
          "chgp": "-32.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "13.92",
          "val2": "12.96",
          "chgp": "7.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-9.05",
          "val2": "1.27",
          "chgp": "-812.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.73%",
          "val2": "6.95%",
          "chgp": "-2.22%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
88.55
79.75
11.03%
Operating Profit (PBDIT) excl Other Income
8.77
8.69
0.92%
Interest
3.49
3.67
-4.90%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.40
2.69
-47.96%
Operating Profit Margin (Excl OI)
9.90%
10.90%
-1.00%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 11.03% vs 4.26% in Sep 2024

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is -47.96% vs 0.37% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
156.25
168.37
-7.20%
Operating Profit (PBDIT) excl Other Income
16.88
-1.28
1,418.75%
Interest
7.41
6.66
11.26%
Exceptional Items
0.00
0.00
Standalone Net Profit
5.37
-13.10
140.99%
Operating Profit Margin (Excl OI)
10.80%
-0.76%
11.56%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -7.20% vs -21.35% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 140.99% vs -350.48% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
244.80
265.42
-7.77%
Operating Profit (PBDIT) excl Other Income
25.65
5.70
350.00%
Interest
10.90
9.97
9.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
6.77
-12.60
153.73%
Operating Profit Margin (Excl OI)
10.46%
2.14%
8.32%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is -7.77% vs -4.18% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 153.73% vs -322.61% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
367.35
370.20
-0.77%
Operating Profit (PBDIT) excl Other Income
17.39
25.73
-32.41%
Interest
13.92
12.96
7.41%
Exceptional Items
0.00
0.00
Standalone Net Profit
-9.05
1.27
-812.60%
Operating Profit Margin (Excl OI)
4.73%
6.95%
-2.22%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -0.77% vs -17.89% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -812.60% vs -93.54% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Mangalam Drugs and Organics Ltd stock-summary
stock-summary
Mangalam Drugs and Organics Ltd
Micro Cap
Pharmaceuticals & Drugs
Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001. The company was promoted by Dhoot family.
Company Coordinates stock-summary
Company Details
3rd Floor Rupam Building, 239 P D Mello Road Mumbai Maharashtra : 400001
stock-summary
Tel: 91-22-22616200/6300/8787
stock-summary
http://www.mangalamdrugs.com
stock-summary
contactus@mangalamdrugs.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."